New Treatment Modality May Reduce Obesity in Schizophrenia Patients

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 17, 2023.

By Elana Gotkine HealthDay Reporter

FRIDAY, Nov. 17, 2023 -- In individuals with schizophrenia, accelerated continuous theta burst stimulation (cTBS) seems promising for treating obesity, according to a study published online Oct. 31 in Schizophrenia Bulletin.

Dongyu Kang, M.D., from The Second Xiangya Hospital of Central South University in Changsha, China, and colleagues conducted a double-blind, randomized trial to examine the efficacy of noninvasive magnetic stimulation techniques in reducing obesity among individuals with schizophrenia. Forty overweight individuals with schizophrenia were recruited and randomly assigned to active intervention, which included 50 accelerated cTBS sessions over the left primary motor area, or sham intervention.

The researchers found that the active group had a significant decrease in body weight and body mass index after the intervention; this improvement persisted at the one-month follow-up. In the active group, the score on the Barratt Impulsivity Scale decreased and mediated the effect of accelerated cTBS on body weight. After the active intervention, the late positive potential component, which is related to motivated attention and emotional processing, decreased in frontal brain regions and increased in posterior regions in the food picture cue electroencephalograph task.

"The intervention was found to be associated with decreased impulsivity and increased motivated attention allocation to food-related cues," the authors write. "These findings are particularly noteworthy, considering the severe metabolic side effects associated with many second-generation antipsychotics."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-18 02:48

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords